Contineum Therapeutics, Inc. Class A Common Stock
USD12.38
-0.71 (-5.42%)
CEO
Carmine N. Stengone
IPO Date
2024-04-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$12.97
Prev. Close
$13.09
Day Low
$12.25
Day High
$13.04
52W Low
$3.57
52W High
$16.33
Market Cap
$0.46B
Volume
0.24M
| 3,870 |
| $13.06 |
| 1 May 2026 | Lorrain Daniel S. | Chief Scientific Officer | S-Sale | Disposed | 300 | $13.84 |
| 6 Apr 2026 | Lorrain Daniel S. | Chief Scientific Officer | S-Sale | Disposed | 4,170 | $13.43 |
| 2 Mar 2026 | Lorrain Daniel S. | Chief Scientific Officer | S-Sale | Disposed | 4,170 | $15.01 |
| 2 Mar 2026 | Watkins Tim | CMO & Head of Development | M-Exempt | Acquired | 3,611 | $4.50 |
| 2 Mar 2026 | Watkins Tim | CMO & Head of Development | S-Sale | Disposed | 3,611 | $15.02 |
| 2 Mar 2026 | Watkins Tim | CMO & Head of Development | M-Exempt | Disposed | 3,611 | $4.50 |
| 26 Feb 2026 | Stengone Carmine N. | director, officer: CEO and President | M-Exempt | Disposed | 2,700 | $1.26 |
| 26 Feb 2026 | Stengone Carmine N. | director, officer: CEO and President | M-Exempt | Acquired | 4,400 | $1.26 |